A rare type of nasal tumor called olfactory neuroblastoma caused ectopic Cushing’s syndrome in a 56-year-old woman, according to a recent case report. The condition was effectively managed with the cortisol-lowering medication metyrapone before being followed by surgery and radiotherapy. After starting metyrapone, the woman developed an opportunistic lung infection,…
News
People with Cushing’s syndrome commonly lose weight after the disorder is treated, a new study found. Findings indicate that nearly half of Cushing’s patients who achieve disease remission lose at least 5% of their total body weight in the years following treatment, and nearly a third lose 10% or…
Prolonged use of high-dose corticosteroid nasal sprays can lead to Cushing’s syndrome in children, according to a case report on a young girl in Italy who was treated with intranasal betamethasone and mometasone furoate for nasal congestion. While it’s well known that Cushing’s syndrome can…
Korlym (mifepristone) lowered the levels of hemoglobin A1c (HbA1c), which reflects the average amount of blood sugar over the past three months, in people with Cushing’s syndrome and treatment-resistant type 2 diabetes. That’s according to newly published data from the now-complete Phase 4 CATALYST (NCT05772169) clinical trial, which…
The first participant has been dosed in a Phase 2 clinical trial testing ST-002 in people with Cushing’s syndrome and high blood sugar levels. “ST-002 has the potential to change the treatment landscape for patients who currently have limited therapeutic options,” Manohar Katakam, PhD, CEO of treatment developer Sterotherapeutics,…
Early screening and treatment for possible underlying causes of obesity, such as Cushing’s disease, before a weight-loss procedure called bariatric surgery may help prevent mismanaging the condition and improve patient outcomes. That’s according to a report that described the case of a man in Iraq who developed complications and…
Sequential treatment with ketoconazole to lower cortisol levels and octreotide to help keep cortisol under control may be effective as a treatment for a subset of people with mild Cushing’s disease, according to a study from the Netherlands. Two of the three patients who responded to treatment, reflected…
Surgery to remove pituitary tumors, the first-line treatment for Cushing’s disease, can increase the risk of venous thromboembolism (VTE), or blood clot formation in veins, especially within a week of the procedure, according to a new study. Identified risk factors for post-surgical VTE include older age, high blood pressure,…
Low-dose aspirin, an antiplatelet agent used to reduce blood clotting, may be better than enoxaparin, the current gold standard, at preventing thromboses in people with Cushing’s syndrome, a U.S. study found. Compared with those on enoxaparin, a form of low-molecular weight heparin (LMWH), patients who took low-dose aspirin had a…
Ectopic Cushing’s syndrome can have different outcomes depending on tumor type, with about 8 in 10 people with lung tumors and 4 in 10 with pancreatic tumors remaining alive five years after diagnosis, according to a meta-analysis study by researchers in Sweden. Patients lived longer when the tumor could…
Recent Posts
- Surgery brings Cushing’s remission to 60% of patients over 20 years: Study
- New Cushing’s disease treatment option reaches Canada with Isturisa
- I’m trying to be more honest about how medical trauma affects me
- CRH test may replace invasive method in diagnosing Cushing’s disease: Study
- Unexpected insulin resistance exposes rare Cushing’s disease diagnosis
- The challenges of managing Cushing’s disease during the postpartum period
- Test may be ‘practical’ alternative for diagnosing Cushing’s in kids
- Man’s aggressive salivary gland cancer triggers Cushing’s syndrome: Report
- FDA rejects relacorilant for Cushing’s-related high blood pressure
- Study supports Isturisa as first-line ectopic Cushing’s treatment